Latest News about Briefs
Recent news which mentions Briefs
From Benzinga
 
   Allegro MicroSystems Being The Leader In Critical Magnetic Sensors For EVs Justifies Premium Valuation: Analyst
   
  
  
  June 16, 2025
  From Benzinga
 From Benzinga
 
   Warner Bros Spin-Off Could Unlock Hidden Value As Ads Rebound, Streaming Gains Momentum: Analyst
   
  
  
  June 16, 2025
  From Benzinga
 
   Kratos Set For Lift-Off Despite Early Turbulence: JPMorgan Spotlights Mid-Cap Defense Firms
   
  
  
  June 16, 2025
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   Applied Materials, CEA-Leti Deepen Partnership To Accelerate Innovation In Specialty Chips
   
  
  
  June 16, 2025
  From Benzinga
 From Benzinga
 
   Eaton Expands High-Margin Defense Portfolio Through Ultra PCS Deal Worth $1.55 Billion
   
  
  
  June 16, 2025
  From Benzinga
 
   Supernus Pharma Acquires Maker Of Postpartum Depression Drug Zurzuvae In $795 Million Deal
   
  
  
  June 16, 2025
  From Benzinga
 From Benzinga
 From Benzinga
 
   Incyte's Experimental Therapy Shows Platelet Normalization And Safety In Rare Blood Cancer Trials Across Doses
   
  
  
  June 16, 2025
  From Benzinga
 From Benzinga
 
   Asia And Europe Markets Rise, Dollar Slips Ahead Of Central Bank Decisions - Global Markets Today While US Slept
   
  
  
  June 16, 2025
  From Benzinga
 
   Sarepta Therapeutics Stock Plummets Over 40% On Second Fatal Case Linked To Its Gene Therapy
   
  
  
  June 16, 2025
  From Benzinga
 From Benzinga
 
   Southwest Airlines To Equip Entire Boeing 737 Fleet With Honeywell's Runway Safety Technology
   
  
  
  June 16, 2025
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   AppLovin, Chewy And Carvana Are Among Top 11 Large Cap Losers Last Week (June 9-13): Are The Others In Your Portfolio?
   
  
  
  June 15, 2025
  From Benzinga
 From Benzinga
 From Benzinga
 
   Adobe Stock Undervalued, Says Analyst As It Breaks From Cautious Tech Pack, Lifts Guidance
   
  
  
  June 13, 2025
  From Benzinga
 
   Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery
   
  
  
  June 13, 2025
  From Benzinga
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

